References
- Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology. 1991;38(sup1):4-8. https://doi.org/10.1016/0090-4295(91)80191-9
- 김동선, 김세철, 김진일, 류수방, 박영요, 박윤규 등. 대한 비뇨기과학회. 비뇨기과학. 제3판. 서울: 고려의학;2001, p. 307-17.
- Edwards JL. Diagnosis and management of benign prostatic hyperplasia. Am Fam Physician. 2008 ;77(10):1403-10.
- Miano R, De Nunzio C, Asimakopoulos AD, Germani S, Tubaro A. Treatment options for benign prostatic hyperplasia in older men. Med Sci Monit. 2008;14(7):94-102.
- McConnell JD. Prostate growth: new insights into hormonal regulation. Br J Urol. 1995;76:5-10. https://doi.org/10.1111/j.1464-410X.1995.tb07864.x
- Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol. 2002;19:413-25.
- Kaplan SA. AUA Guidelines and Their Impact on the Management of BPH: An Update. Rev Urol. 2004;6:46-52.
- O'Leary MP. Tamsulosin: current clinical experience. Urology. 2001;58(6):42-8. https://doi.org/10.1016/S0090-4295(01)01346-2
- 변부형, 서부일, 신상기. 전립선비대증의 동서의학적 고찰. 제한동의학술원 논문집. 1999;4(1):542-57.
- 김호철. 한약약리학. 서울: 집문당; 2001, p.327-9.
- Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH. Recent advances in the investigation of curcuminoids. Chin Med. 2008;3:11. https://doi.org/10.1186/1749-8546-3-11
- Shankar S, Chen Q, Sarva K, SiddiquiI, Srivastava RK. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal. 2007;2:10. https://doi.org/10.1186/1750-2187-2-10
- Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30(4) :905-18.
- Guo QL, Ding QL, Wu ZQ. effect of baicalein on experimental prostatic hyperplasia in rats and mice. Biol Pharm Bull. 2004;27(3):333-7. https://doi.org/10.1248/bpb.27.333
- Sun H, Li TJ, Sun LN, Qiu Y, Huang BB, Yi B, et al. Inhibitory effect of traditional Chinese medicine Zi-Shen Pill on benign prostatic hyperplasia in rats. J Ethnopharmacol. 2008 ;115(2):203-8. https://doi.org/10.1016/j.jep.2007.09.026
- Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474-9.
- Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int. 2006;97(sup2):34-8. https://doi.org/10.1111/j.1464-410X.2006.06104.x
- Sinha R, Anderson DE, McDonald SS, Greenwald P. Cancer risk and diet in India. J Postgrad Med. 2003;49(3):222-8.
- Liao S, Lin J, Dang MT, Zhang H, Kao YH, Fukuchi J, et al. Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Arch Dermatol Res. 2001;293(4):200-5. https://doi.org/10.1007/s004030000203
- 박청, 박종일, 윤은진, 송경섭, 김종석, 김영래 등. 백서에서 고환적출 후 복측전립선의 Apoptosis 기전. 대한내분비학회지. 2005;20(3):230-41.
- Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Arch Physiol Biochem. 2008;114(2):127-49 https://doi.org/10.1080/13813450802033958
- Chagas MA, Babinski MA, Costa WS, Sampaio FJ. Stromal and acinar components of the transition zone in normal and hyperplastic human prostate. BJU Int. 2002;89(7):699-702. https://doi.org/10.1046/j.1464-410X.2002.02724.x
- Rittmaster RS, Norman RW, Thomas LN, Rowden G. Evidence for atrophy and apoptosis in the prostates of men given finasteride. J Clin Endocrinol Metab. 1996;81(2):814-9. https://doi.org/10.1210/jc.81.2.814
- de Voogt HJ. The position of cyproterone acetate(CPA), a steroidal anti-androgen, in the treatment of prostate cancer. Prostate. 1992;4:91-5.